Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Shares withheld for taxes SVP, Products Business gave up 85 shares (to pay taxes)
  2. 4 Planned sale Director sold 3,530 shares at an average $8.36 ($29,527)
  3. 8-K Event Regulation FD disclosure
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 4 Grant or award SVP, Products Business acquired 13,847 shares (grant or award)
  7. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 46,155 shares (grant or award)
  8. 4 Grant or award EVP, Ext Aff, GC, Corp Sec acquired 73,847 shares (grant or award)
  9. 4 Grant or award EVP, Chief Financial Officer acquired 73,847 shares (grant or award)
  10. 4 Grant or award EVP, Business Operations acquired 73,847 shares (grant or award)
  11. 4 Grant or award President and CEO acquired 212,308 shares (grant or award)
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 8-K Event Executive or director change · Shareholder vote results · Regulation FD disclosure
  14. 4 Grant or award Director acquired 33,847 shares (grant or award)
  15. 4 Grant or award Director acquired 33,847 shares (grant or award)
  16. 4 Grant or award Director acquired 33,847 shares (grant or award)
  17. 4 Grant or award Director acquired 33,847 shares (grant or award)
  18. 4 Grant or award Director acquired 33,847 shares (grant or award)
  19. 4 Grant or award Director acquired 33,847 shares (grant or award)
  20. 4 Grant or award Chairman acquired 33,847 shares (grant or award)

Page 16 of 87 · 1,733 filings